268 related articles for article (PubMed ID: 30767810)
1. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities.
Rutala WA; Kanamori H; Gergen MF; Sickbert-Bennett EE; Weber DJ
Infect Control Hosp Epidemiol; 2019 Mar; 40(3):380-382. PubMed ID: 30767810
[TBL] [Abstract][Full Text] [Related]
2. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Forsberg K; Woodworth K; Walters M; Berkow EL; Jackson B; Chiller T; Vallabhaneni S
Med Mycol; 2019 Jan; 57(1):1-12. PubMed ID: 30085270
[TBL] [Abstract][Full Text] [Related]
3. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting.
Kenters N; Kiernan M; Chowdhary A; Denning DW; Pemán J; Saris K; Schelenz S; Tartari E; Widmer A; Meis JF; Voss A
Int J Antimicrob Agents; 2019 Oct; 54(4):400-406. PubMed ID: 31419480
[TBL] [Abstract][Full Text] [Related]
4. Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris.
Weber DJ; Rutala WA; Sickbert-Bennett E
Am J Infect Control; 2023 Nov; 51(11S):A22-A34. PubMed ID: 37890950
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615.
Müller P; Tan CK; Ißleib U; Paßvogel L; Eilts B; Steinhauer K
J Hosp Infect; 2020 Aug; 105(4):648-656. PubMed ID: 32454076
[TBL] [Abstract][Full Text] [Related]
6. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
[TBL] [Abstract][Full Text] [Related]
7. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface.
Welsh RM; Bentz ML; Shams A; Houston H; Lyons A; Rose LJ; Litvintseva AP
J Clin Microbiol; 2017 Oct; 55(10):2996-3005. PubMed ID: 28747370
[TBL] [Abstract][Full Text] [Related]
8. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions.
Biswal M; Rudramurthy SM; Jain N; Shamanth AS; Sharma D; Jain K; Yaddanapudi LN; Chakrabarti A
J Hosp Infect; 2017 Dec; 97(4):363-370. PubMed ID: 28939316
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.
Ong CW; Chen SC; Clark JE; Halliday CL; Kidd SE; Marriott DJ; Marshall CL; Morris AJ; Morrissey CO; Roy R; Slavin MA; Stewardson AJ; Worth LJ; Heath CH;
Intern Med J; 2019 Oct; 49(10):1229-1243. PubMed ID: 31424595
[TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
Abdolrasouli A; Armstrong-James D; Ryan L; Schelenz S
Mycoses; 2017 Nov; 60(11):758-763. PubMed ID: 28872735
[TBL] [Abstract][Full Text] [Related]
11. Emerging strategies for environmental decontamination of the nosocomial fungal pathogen
Bandara HMHN; Samaranayake LP
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35687657
[No Abstract] [Full Text] [Related]
12. Candida auris: an Emerging Fungal Pathogen.
Spivak ES; Hanson KE
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167291
[No Abstract] [Full Text] [Related]
13. Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species.
Silverman J; Vazquez JA; Sobel JD; Zervos MJ
Infect Control Hosp Epidemiol; 1999 Oct; 20(10):676-84. PubMed ID: 10530645
[TBL] [Abstract][Full Text] [Related]
14. Preparing your healthcare facility for the new fungus among us: An infection preventionist's guide to Candida auris.
Wang TZ; White KN; Scarr JV; Simon MS; Calfee DP
Am J Infect Control; 2020 Jul; 48(7):825-827. PubMed ID: 32591096
[TBL] [Abstract][Full Text] [Related]
15. Candida auris outbreak: Mortality, interventions and cost of sustaining control.
Taori SK; Khonyongwa K; Hayden I; Athukorala GDA; Letters A; Fife A; Desai N; Borman AM
J Infect; 2019 Dec; 79(6):601-611. PubMed ID: 31557493
[TBL] [Abstract][Full Text] [Related]
16. Attack, Defend and Persist: How the Fungal Pathogen Candida auris was Able to Emerge Globally in Healthcare Environments.
de Jong AW; Hagen F
Mycopathologia; 2019 Jun; 184(3):353-365. PubMed ID: 31209693
[TBL] [Abstract][Full Text] [Related]
17. Candida auris-the growing menace to global health.
Lone SA; Ahmad A
Mycoses; 2019 Aug; 62(8):620-637. PubMed ID: 30773703
[TBL] [Abstract][Full Text] [Related]
18.
Ku TSN; Walraven CJ; Lee SA
Front Microbiol; 2018; 9():726. PubMed ID: 29706945
[No Abstract] [Full Text] [Related]
19. The comparative efficacy of antiseptics against Candida auris biofilms.
Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
[TBL] [Abstract][Full Text] [Related]
20. Surface disinfection challenges for Candida auris: an in-vitro study.
Kean R; Sherry L; Townsend E; McKloud E; Short B; Akinbobola A; Mackay WG; Williams C; Jones BL; Ramage G
J Hosp Infect; 2018 Apr; 98(4):433-436. PubMed ID: 29203448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
